Cardiometabolic risk and the MTHFR C677T variant in children treated with second-generation antipsychotics

Second-generation antipsychotics (SGAs) are increasingly being used to treat children with a variety of psychiatric illnesses. Metabolic syndrome (MetS), a risk factor for cardiovascular disease, is a side-effect of SGA-treatment. We conducted a cross-sectional study and assessed the association of...

Descripción completa

Detalles Bibliográficos
Autores principales: Devlin, A M, Ngai, Y F, Ronsley, R, Panagiotopoulos, C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2012
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3309538/
https://www.ncbi.nlm.nih.gov/pubmed/22832733
http://dx.doi.org/10.1038/tp.2011.68

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3309538/
https://www.ncbi.nlm.nih.gov/pubmed/22832733
http://dx.doi.org/10.1038/tp.2011.68

Ejemplares similares